Class information for:
Level 1: RIMONABANT//TARANABANT//ENDOCANNABINOIDS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
8995 1130 46.6 87%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
689 12387 ANANDAMIDE//CANNABINOID//CANNABINOIDS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 RIMONABANT Author keyword 57 33% 13% 144
2 TARANABANT Author keyword 21 75% 1% 15
3 ENDOCANNABINOIDS Author keyword 12 11% 8% 96
4 SR141716 Author keyword 11 35% 2% 25
5 ENDOCANNABINOID SYSTEM Author keyword 9 16% 5% 51
6 CANNABINOID 1 RECEPTOR INVERSE AGONIST Author keyword 9 83% 0% 5
7 CANNABINOID RECEPTOR GENE Author keyword 9 67% 1% 8
8 CNR1 POLYMORPHISM Author keyword 8 100% 0% 5
9 CB1 Author keyword 7 13% 5% 52
10 CANNABINOID RECEPTOR 1 Author keyword 7 28% 2% 22

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 RIMONABANT 57 33% 13% 144 Search RIMONABANT Search RIMONABANT
2 TARANABANT 21 75% 1% 15 Search TARANABANT Search TARANABANT
3 ENDOCANNABINOIDS 12 11% 8% 96 Search ENDOCANNABINOIDS Search ENDOCANNABINOIDS
4 SR141716 11 35% 2% 25 Search SR141716 Search SR141716
5 ENDOCANNABINOID SYSTEM 9 16% 5% 51 Search ENDOCANNABINOID+SYSTEM Search ENDOCANNABINOID+SYSTEM
6 CANNABINOID 1 RECEPTOR INVERSE AGONIST 9 83% 0% 5 Search CANNABINOID+1+RECEPTOR+INVERSE+AGONIST Search CANNABINOID+1+RECEPTOR+INVERSE+AGONIST
7 CANNABINOID RECEPTOR GENE 9 67% 1% 8 Search CANNABINOID+RECEPTOR+GENE Search CANNABINOID+RECEPTOR+GENE
8 CNR1 POLYMORPHISM 8 100% 0% 5 Search CNR1+POLYMORPHISM Search CNR1+POLYMORPHISM
9 CB1 7 13% 5% 52 Search CB1 Search CB1
10 CANNABINOID RECEPTOR 1 7 28% 2% 22 Search CANNABINOID+RECEPTOR+1 Search CANNABINOID+RECEPTOR+1

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 RIMONABANT 136 55% 15% 168
2 ANTAGONIST SR141716 96 88% 4% 45
3 OVERWEIGHT PATIENTS 80 39% 14% 160
4 MK 0364 61 95% 2% 20
5 SR141716 54 74% 4% 40
6 SR 141716 48 58% 5% 56
7 CARDIOMETABOLIC RISK FACTORS 45 38% 8% 96
8 ENDOCANNABINOID SYSTEM 41 14% 24% 266
9 RECEPTOR ANTAGONIST SR141716 33 83% 2% 19
10 CB1 RECEPTOR ANTAGONIST 31 38% 6% 66

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders 2013 45 145 70%
The endocannabinoid system: directing eating behavior and macronutrient metabolism 2015 2 81 42%
The role of the endocannabinoid system in the neuroendocrine regulation of energy balance 2012 35 97 59%
The endocannabinoid system in obesity and type 2 diabetes 2008 114 73 73%
The case for peripheral CB1 receptor blockade in the treatment of visceral obesity and its cardiometabolic complications 2011 41 79 67%
The Current Status and Future Perspectives of Studies of Cannabinoid Receptor 1 Antagonists as Anti-Obesity Agents 2009 57 110 76%
The endocannabinoid system, eating behavior and energy homeostasis: The end or a new beginning? 2010 64 71 58%
Energy balance regulation by endocannabinoids at central and peripheral levels 2011 28 81 81%
Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders 2012 21 112 73%
An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity 2011 39 23 57%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ENDOCANNABINOID GRP 7 12% 4.6% 52
2 SMALL MOL GRP 4 75% 0.3% 3
3 MED REGENERAT 4 25% 1.2% 14
4 GRP ENERGY BALANCE OBES 3 60% 0.3% 3
5 UNIT INVEST 2 12% 1.6% 18
6 CIBER OBN INVEST BIOMED RED FISIOPATOL OBESID 2 67% 0.2% 2
7 ISLET CELL BIOL REGENERAT MED 2 67% 0.2% 2
8 NEURO MAGENDIE PHYSIOPATHOL PLASTICITE NEURONA 2 67% 0.2% 2
9 FDN IMABIS 2 12% 1.5% 17
10 HOSP RIO HORTEGA 2 11% 1.6% 18

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000203768 ANANDAMIDE//FATTY ACID AMIDE HYDROLASE//CANNABINOID
2 0.0000203483 CANNABINOID//DELTA9 TETRAHYDROCANNABINOL//CANNABINOIDS
3 0.0000117900 SIBUTRAMINE//ORLISTAT//ANTIOBESITY DRUGS
4 0.0000101273 SEZ BOTTAZZI//SEZ F BOTTAZZI//UNIV RIC SVILUPPO GEST RISORSE AMBIENTE MAR
5 0.0000045628 FOOD ADDICTION//YALE FOOD ADDICTION SCALE//HLTH BEHAV NEUROSCI
6 0.0000042289 CANNABIS//MARIJUANA//NABIXIMOLS
7 0.0000032633 HYPOTHALAM//A2 NORADRENERGIC NEURONS//LASER CATAPULT MICRODISSECTION
8 0.0000032009 NOR BINALTORPHAMINE//MINNESOTA OBES//NEUROPSYCHOL DOCTORAL SUB PROGRAM
9 0.0000028163 DIHYDROPYRAZOLE//OXIME ESTER//ULCEROGENIC EFFECT
10 0.0000028139 PYRAZOLES//WITHASOMNINE//PYRAZOLE 35 CARBOXYLIC ACID